APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Selected research

Market Analysis & Forecast

Global Quetiapine Fumarate Market Analysis and Forecast 2026-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Read the full market overview

This report presents an overview of global market for Quetiapine Fumarate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Quetiapine Fumarate, also provides the sales of main regions and countries. Of the upcoming market potential for Quetiapine Fumarate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Quetiapine Fumarate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Quetiapine Fumarate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Quetiapine Fumarate sales, projected growth trends, production technology, application and end-user industry.

Quetiapine Fumarate Segment by Company

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy's

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Quetiapine Fumarate Segment by Type

Immediate Release Tablets

Extended Release Tablets

Quetiapine Fumarate Segment by Application

Adult

Others

Quetiapine Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Quetiapine Fumarate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Quetiapine Fumarate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immediate Release Tablets Major Manufacturers Table 3. Extended Release Tablets Major Manufacturers Table 4. Global Quetiapine Fumarate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adult Major Manufacturers Table 6. Others Major Manufacturers Table 7. Quetiapine Fumarate Industry Trends Table 8. Quetiapine Fumarate Industry Drivers Table 9. Quetiapine Fumarate Industry Opportunities and Challenges Table 10. Quetiapine Fumarate Industry Restraints Table 11. Global Quetiapine Fumarate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Quetiapine Fumarate Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Quetiapine Fumarate Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Quetiapine Fumarate Revenue Market Share by Region (2021-2026) Table 15. Global Quetiapine Fumarate Revenue Market Share by Region (2027-2032) Table 16. Global Quetiapine Fumarate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 17. Global Quetiapine Fumarate Sales by Region (2021-2026) & (t) Table 18. Global Quetiapine Fumarate Sales by Region (2027-2032) & (t) Table 19. Global Quetiapine Fumarate Sales Market Share by Region (2021-2026) Table 20. Global Quetiapine Fumarate Sales Market Share by Region (2027-2032) Table 21. Global Quetiapine Fumarate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Quetiapine Fumarate Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021-2026) Table 25. Global Quetiapine Fumarate Sales Price (USD/kg) of Manufacturers (2021-2026) Table 26. Global Quetiapine Fumarate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Quetiapine Fumarate Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Quetiapine Fumarate Manufacturers, Product Type & Application Table 29. Global Quetiapine Fumarate Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Quetiapine Fumarate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Quetiapine Fumarate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Quetiapine Fumarate Revenue Market Share by Type (2021-2026) Table 36. Global Quetiapine Fumarate Revenue Market Share by Type (2027-2032) Table 37. Global Quetiapine Fumarate Sales by Type 2021 VS 2025 VS 2032 (t) Table 38. Global Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 39. Global Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 40. Global Quetiapine Fumarate Sales Market Share by Type (2021-2026) Table 41. Global Quetiapine Fumarate Sales Market Share by Type (2027-2032) Table 42. Global Quetiapine Fumarate Price by Type (2021-2026) & (USD/kg) Table 43. Global Quetiapine Fumarate Price by Type (2027-2032) & (USD/kg) Table 44. Global Quetiapine Fumarate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Quetiapine Fumarate Revenue Market Share by Application (2021-2026) Table 48. Global Quetiapine Fumarate Revenue Market Share by Application (2027-2032) Table 49. Global Quetiapine Fumarate Sales by Application 2021 VS 2025 VS 2032 (t) Table 50. Global Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 51. Global Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 52. Global Quetiapine Fumarate Sales Market Share by Application (2021-2026) Table 53. Global Quetiapine Fumarate Sales Market Share by Application (2027-2032) Table 54. Global Quetiapine Fumarate Price by Application (2021-2026) & (USD/kg) Table 55. Global Quetiapine Fumarate Price by Application (2027-2032) & (USD/kg) Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 59. AstraZeneca Quetiapine Fumarate Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Intas Company Information Table 62. Intas Business Overview Table 63. Intas Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 64. Intas Quetiapine Fumarate Product Portfolio Table 65. Intas Recent Development Table 66. TAPI Company Information Table 67. TAPI Business Overview Table 68. TAPI Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 69. TAPI Quetiapine Fumarate Product Portfolio Table 70. TAPI Recent Development Table 71. Accord Company Information Table 72. Accord Business Overview Table 73. Accord Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Accord Quetiapine Fumarate Product Portfolio Table 75. Accord Recent Development Table 76. Hexal Company Information Table 77. Hexal Business Overview Table 78. Hexal Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Hexal Quetiapine Fumarate Product Portfolio Table 80. Hexal Recent Development Table 81. Dr.Reddy's Company Information Table 82. Dr.Reddy's Business Overview Table 83. Dr.Reddy's Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Dr.Reddy's Quetiapine Fumarate Product Portfolio Table 85. Dr.Reddy's Recent Development Table 86. Lupin Company Information Table 87. Lupin Business Overview Table 88. Lupin Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Lupin Quetiapine Fumarate Product Portfolio Table 90. Lupin Recent Development Table 91. Sun Pharmaceutical Company Information Table 92. Sun Pharmaceutical Business Overview Table 93. Sun Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Sun Pharmaceutical Quetiapine Fumarate Product Portfolio Table 95. Sun Pharmaceutical Recent Development Table 96. Hunan Dongting Pharm Company Information Table 97. Hunan Dongting Pharm Business Overview Table 98. Hunan Dongting Pharm Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio Table 100. Hunan Dongting Pharm Recent Development Table 101. SuZhou NO.4 Phamaceutical Factory Company Information Table 102. SuZhou NO.4 Phamaceutical Factory Business Overview Table 103. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio Table 105. SuZhou NO.4 Phamaceutical Factory Recent Development Table 106. Fuan Pharmaceutical Company Information Table 107. Fuan Pharmaceutical Business Overview Table 108. Fuan Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio Table 110. Fuan Pharmaceutical Recent Development Table 111. Zhejiang Supor Pharmaceuticals Company Information Table 112. Zhejiang Supor Pharmaceuticals Business Overview Table 113. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio Table 115. Zhejiang Supor Pharmaceuticals Recent Development Table 116. Zhejiang Huahai Pharmaceutical Company Information Table 117. Zhejiang Huahai Pharmaceutical Business Overview Table 118. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio Table 120. Zhejiang Huahai Pharmaceutical Recent Development Table 121. North America Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 124. North America Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 125. North America Quetiapine Fumarate Sales Price by Type (2021-2026) & (USD/kg) Table 126. North America Quetiapine Fumarate Sales Price by Type (2027-2032) & (USD/kg) Table 127. North America Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 130. North America Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 131. North America Quetiapine Fumarate Sales Price by Application (2021-2026) & (USD/kg) Table 132. North America Quetiapine Fumarate Sales Price by Application (2027-2032) & (USD/kg) Table 133. North America Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Quetiapine Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. North America Quetiapine Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. North America Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032) & (t) Table 137. North America Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 138. North America Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 139. North America Quetiapine Fumarate Sales Price by Country (2021-2026) & (USD/kg) Table 140. North America Quetiapine Fumarate Sales Price by Country (2027-2032) & (USD/kg) Table 141. United States Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 142. Canada Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 143. Mexico Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 144. Europe Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 147. Europe Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 148. Europe Quetiapine Fumarate Sales Price by Type (2021-2026) & (USD/kg) Table 149. Europe Quetiapine Fumarate Sales Price by Type (2027-2032) & (USD/kg) Table 150. Europe Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 153. Europe Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 154. Europe Quetiapine Fumarate Sales Price by Application (2021-2026) & (USD/kg) Table 155. Europe Quetiapine Fumarate Sales Price by Application (2027-2032) & (USD/kg) Table 156. Europe Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Quetiapine Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Quetiapine Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032) & (t) Table 160. Europe Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 161. Europe Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 162. Europe Quetiapine Fumarate Sales Price by Country (2021-2026) & (USD/kg) Table 163. Europe Quetiapine Fumarate Sales Price by Country (2027-2032) & (USD/kg) Table 164. Germany Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 165. France Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 166. U.K. Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 167. Italy Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 168. Russia Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 169. Spain Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 170. Netherlands Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 171. Switzerland Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 172. Sweden Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 173. Poland Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 174. China Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 175. China Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 176. China Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 177. China Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 178. China Quetiapine Fumarate Sales Price by Type (2021-2026) & (USD/kg) Table 179. China Quetiapine Fumarate Sales Price by Type (2027-2032) & (USD/kg) Table 180. China Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 181. China Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 182. China Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 183. China Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 184. China Quetiapine Fumarate Sales Price by Application (2021-2026) & (USD/kg) Table 185. China Quetiapine Fumarate Sales Price by Application (2027-2032) & (USD/kg) Table 186. Asia Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 187. Asia Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 188. Asia Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 189. Asia Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 190. Asia Quetiapine Fumarate Sales Price by Type (2021-2026) & (USD/kg) Table 191. Asia Quetiapine Fumarate Sales Price by Type (2027-2032) & (USD/kg) Table 192. Asia Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 193. Asia Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 194. Asia Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 195. Asia Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 196. Asia Quetiapine Fumarate Sales Price by Application (2021-2026) & (USD/kg) Table 197. Asia Quetiapine Fumarate Sales Price by Application (2027-2032) & (USD/kg) Table 198. Asia Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Asia Quetiapine Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Asia Quetiapine Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Asia Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032) & (t) Table 202. Asia Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 203. Asia Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 204. Asia Quetiapine Fumarate Sales Price by Country (2021-2026) & (USD/kg) Table 205. Asia Quetiapine Fumarate Sales Price by Country (2027-2032) & (USD/kg) Table 206. Japan Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 207. South Korea Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 208. India Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 209. Australia Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 210. Taiwan Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 211. Southeast Asia Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 212. SAMEA Quetiapine Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 213. SAMEA Quetiapine Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 214. SAMEA Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 215. SAMEA Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 216. SAMEA Quetiapine Fumarate Sales Price by Type (2021-2026) & (USD/kg) Table 217. SAMEA Quetiapine Fumarate Sales Price by Type (2027-2032) & (USD/kg) Table 218. SAMEA Quetiapine Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 219. SAMEA Quetiapine Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 220. SAMEA Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 221. SAMEA Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 222. SAMEA Quetiapine Fumarate Sales Price by Application (2021-2026) & (USD/kg) Table 223. SAMEA Quetiapine Fumarate Sales Price by Application (2027-2032) & (USD/kg) Table 224. SAMEA Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. SAMEA Quetiapine Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. SAMEA Quetiapine Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. SAMEA Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032) & (t) Table 228. SAMEA Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 229. SAMEA Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 230. SAMEA Quetiapine Fumarate Sales Price by Country (2021-2026) & (USD/kg) Table 231. SAMEA Quetiapine Fumarate Sales Price by Country (2027-2032) & (USD/kg) Table 232. Brazil Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 233. Argentina Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 234. Chile Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 235. Colombia Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 236. Peru Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 237. Saudi Arabia Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 238. Israel Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 239. UAE Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 240. Turkey Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 241. Iran Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 242. Egypt Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Table 243. Key Raw Materials Table 244. Raw Materials Key Suppliers Table 245. Quetiapine Fumarate Distributors List Table 246. Quetiapine Fumarate Customers List Table 247. Research Programs/Design for This Report Table 248. Authors List of This Report Table 249. Secondary Sources Table 250. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Image Figure 2. Global Quetiapine Fumarate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immediate Release Tablets Image Figure 5. Extended Release Tablets Image Figure 6. Global Quetiapine Fumarate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Quetiapine Fumarate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adult Image Figure 9. Others Image Figure 10. Global Quetiapine Fumarate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Figure 12. Global Quetiapine Fumarate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Quetiapine Fumarate Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Quetiapine Fumarate Revenue Market Share by Region (2021-2032) Figure 15. Global Quetiapine Fumarate Sales (2021-2032) & (t) Figure 16. Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 17. Global Quetiapine Fumarate Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Quetiapine Fumarate Sales YoY (2021-2032) & (t) Figure 19. Europe Quetiapine Fumarate Sales YoY (2021-2032) & (t) Figure 20. China Quetiapine Fumarate Sales YoY (2021-2032) & (t) Figure 21. Asia (Excluding China) Quetiapine Fumarate Sales YoY (2021-2032) & (t) Figure 22. South America, Middle East and Africa Quetiapine Fumarate Sales YoY (2021-2032) & (t) Figure 23. Global Quetiapine Fumarate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Quetiapine Fumarate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Quetiapine Fumarate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Quetiapine Fumarate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Quetiapine Fumarate Revenue Market Share by Type (2021-2032) Figure 29. Global Quetiapine Fumarate Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 30. Global Quetiapine Fumarate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Quetiapine Fumarate Sales Market Share by Type (2021-2032) Figure 32. Global Quetiapine Fumarate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Quetiapine Fumarate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Quetiapine Fumarate Revenue Market Share by Application (2021-2032) Figure 35. Global Quetiapine Fumarate Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 36. Global Quetiapine Fumarate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Quetiapine Fumarate Sales Market Share by Application (2021-2032) Figure 38. North America Quetiapine Fumarate Revenue Share by Type (2021-2032) Figure 39. North America Quetiapine Fumarate Sales Share by Type (2021-2032) Figure 40. North America Quetiapine Fumarate Revenue Share by Application (2021-2032) Figure 41. North America Quetiapine Fumarate Sales Share by Application (2021-2032) Figure 42. North America Quetiapine Fumarate Revenue Share by Country (2021-2032) Figure 43. North America Quetiapine Fumarate Sales Share by Country (2021-2032) Figure 44. Europe Quetiapine Fumarate Revenue Share by Type (2021-2032) Figure 45. Europe Quetiapine Fumarate Sales Share by Type (2021-2032) Figure 46. Europe Quetiapine Fumarate Revenue Share by Application (2021-2032) Figure 47. Europe Quetiapine Fumarate Sales Share by Application (2021-2032) Figure 48. Europe Quetiapine Fumarate Revenue Share by Country (2021-2032) Figure 49. Europe Quetiapine Fumarate Sales Share by Country (2021-2032) Figure 50. China Quetiapine Fumarate Revenue Share by Type (2021-2032) Figure 51. China Quetiapine Fumarate Sales Share by Type (2021-2032) Figure 52. China Quetiapine Fumarate Revenue Share by Application (2021-2032) Figure 53. China Quetiapine Fumarate Sales Share by Application (2021-2032) Figure 54. Asia Quetiapine Fumarate Revenue Share by Type (2021-2032) Figure 55. Asia Quetiapine Fumarate Sales Share by Type (2021-2032) Figure 56. Asia Quetiapine Fumarate Revenue Share by Application (2021-2032) Figure 57. Asia Quetiapine Fumarate Sales Share by Application (2021-2032) Figure 58. Asia Quetiapine Fumarate Revenue Share by Country (2021-2032) Figure 59. Asia Quetiapine Fumarate Sales Share by Country (2021-2032) Figure 60. SAMEA Quetiapine Fumarate Revenue Share by Type (2021-2032) Figure 61. SAMEA Quetiapine Fumarate Sales Share by Type (2021-2032) Figure 62. SAMEA Quetiapine Fumarate Revenue Share by Application (2021-2032) Figure 63. SAMEA Quetiapine Fumarate Sales Share by Application (2021-2032) Figure 64. SAMEA Quetiapine Fumarate Revenue Share by Country (2021-2032) Figure 65. SAMEA Quetiapine Fumarate Sales Share by Country (2021-2032) Figure 66. Quetiapine Fumarate Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Quetiapine Fumarate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release Tablets
  • Extended Release Tablets
Applications
  • Adult
  • Others
Companies covered
  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Quetiapine Fumarate Market by Type
  3. 1.2.1 Global Quetiapine Fumarate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immediate Release Tablets
  5. 1.2.3 Extended Release Tablets
  6. 1.3 Quetiapine Fumarate Market by Application
  7. 1.3.1 Global Quetiapine Fumarate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adult
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Quetiapine Fumarate Market Dynamics
  1. 2.1 Quetiapine Fumarate Industry Trends
  2. 2.2 Quetiapine Fumarate Industry Drivers
  3. 2.3 Quetiapine Fumarate Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Quetiapine Fumarate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Quetiapine Fumarate Revenue by Region
  3. 3.2.1 Global Quetiapine Fumarate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Quetiapine Fumarate Revenue by Region (2021-2026)
  5. 3.2.3 Global Quetiapine Fumarate Revenue by Region (2027-2032)
  6. 3.2.4 Global Quetiapine Fumarate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Quetiapine Fumarate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Quetiapine Fumarate Sales by Region
  9. 3.4.1 Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Quetiapine Fumarate Sales by Region (2021-2026)
  11. 3.4.3 Global Quetiapine Fumarate Sales by Region (2027-2032)
  12. 3.4.4 Global Quetiapine Fumarate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Quetiapine Fumarate Revenue by Manufacturers
  2. 4.1.1 Global Quetiapine Fumarate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Quetiapine Fumarate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Quetiapine Fumarate Sales by Manufacturers
  6. 4.2.1 Global Quetiapine Fumarate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Quetiapine Fumarate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Quetiapine Fumarate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Quetiapine Fumarate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Quetiapine Fumarate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Quetiapine Fumarate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Quetiapine Fumarate Manufacturers, Product Type & Application
  13. 4.7 Global Quetiapine Fumarate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Quetiapine Fumarate Market CR5 and HHI
  16. 4.8.2 2025 Quetiapine Fumarate Tier 1, Tier 2, and Tier 3
5 Quetiapine Fumarate Market by Type
  1. 5.1 Global Quetiapine Fumarate Revenue by Type
  2. 5.1.1 Global Quetiapine Fumarate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Quetiapine Fumarate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Quetiapine Fumarate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Quetiapine Fumarate Sales by Type
  6. 5.2.1 Global Quetiapine Fumarate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Quetiapine Fumarate Sales by Type (2021-2032) & (t)
  8. 5.2.3 Global Quetiapine Fumarate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Quetiapine Fumarate Price by Type
6 Quetiapine Fumarate Market by Application
  1. 6.1 Global Quetiapine Fumarate Revenue by Application
  2. 6.1.1 Global Quetiapine Fumarate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Quetiapine Fumarate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Quetiapine Fumarate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Quetiapine Fumarate Sales by Application
  6. 6.2.1 Global Quetiapine Fumarate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Quetiapine Fumarate Sales by Application (2021-2032) & (t)
  8. 6.2.3 Global Quetiapine Fumarate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Quetiapine Fumarate Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 Intas
  8. 7.2.1 Intas Company Information
  9. 7.2.2 Intas Business Overview
  10. 7.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Intas Quetiapine Fumarate Product Portfolio
  12. 7.2.5 Intas Recent Developments
  13. 7.3 TAPI
  14. 7.3.1 TAPI Company Information
  15. 7.3.2 TAPI Business Overview
  16. 7.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TAPI Quetiapine Fumarate Product Portfolio
  18. 7.3.5 TAPI Recent Developments
  19. 7.4 Accord
  20. 7.4.1 Accord Company Information
  21. 7.4.2 Accord Business Overview
  22. 7.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Accord Quetiapine Fumarate Product Portfolio
  24. 7.4.5 Accord Recent Developments
  25. 7.5 Hexal
  26. 7.5.1 Hexal Company Information
  27. 7.5.2 Hexal Business Overview
  28. 7.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hexal Quetiapine Fumarate Product Portfolio
  30. 7.5.5 Hexal Recent Developments
  31. 7.6 Dr.Reddy's
  32. 7.6.1 Dr.Reddy's Company Information
  33. 7.6.2 Dr.Reddy's Business Overview
  34. 7.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
  36. 7.6.5 Dr.Reddy's Recent Developments
  37. 7.7 Lupin
  38. 7.7.1 Lupin Company Information
  39. 7.7.2 Lupin Business Overview
  40. 7.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lupin Quetiapine Fumarate Product Portfolio
  42. 7.7.5 Lupin Recent Developments
  43. 7.8 Sun Pharmaceutical
  44. 7.8.1 Sun Pharmaceutical Company Information
  45. 7.8.2 Sun Pharmaceutical Business Overview
  46. 7.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
  48. 7.8.5 Sun Pharmaceutical Recent Developments
  49. 7.9 Hunan Dongting Pharm
  50. 7.9.1 Hunan Dongting Pharm Company Information
  51. 7.9.2 Hunan Dongting Pharm Business Overview
  52. 7.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
  54. 7.9.5 Hunan Dongting Pharm Recent Developments
  55. 7.10 SuZhou NO.4 Phamaceutical Factory
  56. 7.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
  57. 7.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
  58. 7.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
  60. 7.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
  61. 7.11 Fuan Pharmaceutical
  62. 7.11.1 Fuan Pharmaceutical Company Information
  63. 7.11.2 Fuan Pharmaceutical Business Overview
  64. 7.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
  66. 7.11.5 Fuan Pharmaceutical Recent Developments
  67. 7.12 Zhejiang Supor Pharmaceuticals
  68. 7.12.1 Zhejiang Supor Pharmaceuticals Company Information
  69. 7.12.2 Zhejiang Supor Pharmaceuticals Business Overview
  70. 7.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
  72. 7.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
  73. 7.13 Zhejiang Huahai Pharmaceutical
  74. 7.13.1 Zhejiang Huahai Pharmaceutical Company Information
  75. 7.13.2 Zhejiang Huahai Pharmaceutical Business Overview
  76. 7.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
  78. 7.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Quetiapine Fumarate Market Size by Type
  2. 8.1.1 North America Quetiapine Fumarate Revenue by Type (2021-2032)
  3. 8.1.2 North America Quetiapine Fumarate Sales by Type (2021-2032)
  4. 8.1.3 North America Quetiapine Fumarate Price by Type (2021-2032)
  5. 8.2 North America Quetiapine Fumarate Market Size by Application
  6. 8.2.1 North America Quetiapine Fumarate Revenue by Application (2021-2032)
  7. 8.2.2 North America Quetiapine Fumarate Sales by Application (2021-2032)
  8. 8.2.3 North America Quetiapine Fumarate Price by Application (2021-2032)
  9. 8.3 North America Quetiapine Fumarate Market Size by Country
  10. 8.3.1 North America Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Quetiapine Fumarate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Quetiapine Fumarate Market Size by Type
  2. 9.1.1 Europe Quetiapine Fumarate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Quetiapine Fumarate Sales by Type (2021-2032)
  4. 9.1.3 Europe Quetiapine Fumarate Price by Type (2021-2032)
  5. 9.2 Europe Quetiapine Fumarate Market Size by Application
  6. 9.2.1 Europe Quetiapine Fumarate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Quetiapine Fumarate Sales by Application (2021-2032)
  8. 9.2.3 Europe Quetiapine Fumarate Price by Application (2021-2032)
  9. 9.3 Europe Quetiapine Fumarate Market Size by Country
  10. 9.3.1 Europe Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Quetiapine Fumarate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Quetiapine Fumarate Market Size by Type
  2. 10.1.1 China Quetiapine Fumarate Revenue by Type (2021-2032)
  3. 10.1.2 China Quetiapine Fumarate Sales by Type (2021-2032)
  4. 10.1.3 China Quetiapine Fumarate Price by Type (2021-2032)
  5. 10.2 China Quetiapine Fumarate Market Size by Application
  6. 10.2.1 China Quetiapine Fumarate Revenue by Application (2021-2032)
  7. 10.2.2 China Quetiapine Fumarate Sales by Application (2021-2032)
  8. 10.2.3 China Quetiapine Fumarate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Quetiapine Fumarate Market Size by Type
  2. 11.1.1 Asia Quetiapine Fumarate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Quetiapine Fumarate Sales by Type (2021-2032)
  4. 11.1.3 Asia Quetiapine Fumarate Price by Type (2021-2032)
  5. 11.2 Asia Quetiapine Fumarate Market Size by Application
  6. 11.2.1 Asia Quetiapine Fumarate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Quetiapine Fumarate Sales by Application (2021-2032)
  8. 11.2.3 Asia Quetiapine Fumarate Price by Application (2021-2032)
  9. 11.3 Asia Quetiapine Fumarate Market Size by Country
  10. 11.3.1 Asia Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Quetiapine Fumarate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Quetiapine Fumarate Market Size by Type
  2. 12.1.1 SAMEA Quetiapine Fumarate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Quetiapine Fumarate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Quetiapine Fumarate Price by Type (2021-2032)
  5. 12.2 SAMEA Quetiapine Fumarate Market Size by Application
  6. 12.2.1 SAMEA Quetiapine Fumarate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Quetiapine Fumarate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Quetiapine Fumarate Price by Application (2021-2032)
  9. 12.3 SAMEA Quetiapine Fumarate Market Size by Country
  10. 12.3.1 SAMEA Quetiapine Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Quetiapine Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Quetiapine Fumarate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Quetiapine Fumarate Value Chain Analysis
  2. 13.1.1 Quetiapine Fumarate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Quetiapine Fumarate Production Mode & Process
  6. 13.2 Quetiapine Fumarate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Quetiapine Fumarate Distributors
  9. 13.2.3 Quetiapine Fumarate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst